2 withdrawn, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 2, Completed 1 |
Follow Vitrectomy: new trials by email Literature Review of Vitrectomy trials Research Report on Vitrectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surgical Stabilizer Assisted RVC With rtPA for CRVO Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse) infusion up to 1mg., Intravenous Infusion - Central Retinal Vein Occlusion | Phase 1 | Withdrawn | Universitaire Ziekenhuizen KU Leuven | 2018-10-16 | 2023-03-23 | |
| Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) vitrectomy with subretinal lucentis - Retinal Hemorrhage, Macular Degeneration | Phase 1 | Withdrawn | Corewell Health East | 2007-09-01 | 2016-08-08 | |
| Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema vitrectomy, intravitreal triamcinolone acetonide, macular focal laser photocoagulation - Diabetic Macular Edema | Phase 1 | Completed | Samsung Medical Center | 2005-04-01 | 2006-09-04 |
Hemorrhage (1) · Macular Degeneration (1) · Retinal Hemorrhage (1) · Retinal Vein Occlusion (1)
Corewell Health East (1) · Samsung Medical Center (1) · Universitaire Ziekenhuizen KU Leuven (1)
Belgium (1) · South Korea (1) · United States (1)
Peter Stalmans (1) · Se Woong Kang, MD (1) · Tarek Hassan, MD (1)